FindTrial
Sign In

Tumor Board Review

OTHER2 trials

Sponsors

SWOG Cancer Research Network, Fred Hutchinson Cancer Center

Conditions

Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmPancreatic NeoplasmRecurrent Malignant Solid NeoplasmRefractory Malignant Solid Neoplasm

Unknown Phase

Does the Use of a Genomic Tumor Board Increase the Number of Patients Who Receive Genome-Informed Treatment
Active, not recruitingNCT05455606
SWOG Cancer Research NetworkAdvanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Recurrent Malignant Solid Neoplasm +1
Start: 2022-10-14End: 2027-03-01Updated: 2026-01-22
Palliative Care Consultation to Improve Communication for Patients Considering Surgery for a Pancreatic Neoplasm
WithdrawnNCT06545344
Fred Hutchinson Cancer CenterPancreatic Neoplasm
Start: 2025-09-01End: 2026-01-01Updated: 2025-06-29

Related Papers

Successful accrual of a cluster randomized controlled trial (RCT) comparing an educationally enhanced genomic tumor board (EGTB) intervention to usual practice (S2108CD, NCT# 05455606).
Journal of Clinical Oncology2025-05-28
Utilization of genomic tumor testing (GTT) among community oncologists participating in SWOG S2108CD.
JCO Oncology Practice2024-09-30
Mixed-methods analysis of physician genomic confidence in the pre-implementation phase of the cluster randomized trial evaluating genomic tumor boards (SWOG S2108CD, NCT05455606).
JCO Oncology Practice2023-10-26